Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
- PMID: 28070157
- PMCID: PMC5192296
- DOI: 10.1155/2016/7348239
Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
Abstract
Background. We performed prospective validation of the cancer ratio (serum LDH : pleural ADA ratio), previously reported as predictive of malignant effusion retrospectively, and assessed the effect of combining it with "pleural lymphocyte count" in diagnosing malignant pleural effusion (MPE). Methods. Prospective cohort study of patients hospitalized with lymphocyte predominant exudative pleural effusion in 2015. Results. 118 patients, 84 (71.2%) having MPE and 34 (28.8%) having tuberculous pleural effusion (TPE), were analysed. In multivariate logistic regression analysis, cancer ratio, serum LDH : pleural fluid lymphocyte count ratio, and "cancer ratio plus" (ratio of cancer ratio and pleural fluid lymphocyte count) correlated positively with MPE. The sensitivity and specificity of cancer ratio, ratio of serum LDH : pleural fluid lymphocyte count, and "cancer ratio plus" were 0.95 (95% CI 0.87-0.98) and 0.85 (95% CI 0.68-0.94), 0.63 (95% CI 0.51-0.73) and 0.85 (95% CI 0.68-0.94), and 97.6 (95% CI 0.90-0.99) and 94.1 (95% CI 0.78-0.98) at the cut-off level of >20, >800, and >30, respectively. Conclusion. Without incurring any additional cost, or requiring additional test, effort, or time, cancer ratio maintained and "cancer ratio plus" improved the specificity of cancer ratio in identifying MPE in the prospective cohort.
Conflict of interest statement
Akash Verma, Rucha S. Dagaonkar, Dominic Marshall, John Abisheganaden, and R. W. Light have no potential competing interests to report.
Figures
Similar articles
-
Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).Lung. 2016 Feb;194(1):147-53. doi: 10.1007/s00408-015-9831-6. Epub 2015 Dec 17. Lung. 2016. PMID: 26678281 Free PMC article.
-
A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.BMC Pulm Med. 2021 Mar 19;21(1):95. doi: 10.1186/s12890-021-01459-w. BMC Pulm Med. 2021. PMID: 33740937 Free PMC article.
-
The role of pleural fluid lactate dehydrogenase-to-adenosine deaminase ratio in differentiating the etiology of pleural effusions.Chin J Physiol. 2022 May-Jun;65(3):105-108. doi: 10.4103/cjp.cjp_104_21. Chin J Physiol. 2022. PMID: 35775528
-
Useful tests on the pleural fluid in the management of patients with pleural effusions.Curr Opin Pulm Med. 1999 Jul;5(4):245-9. doi: 10.1097/00063198-199907000-00012. Curr Opin Pulm Med. 1999. PMID: 10407695 Review.
-
Diagnostic Accuracy of Interleukin-27 between Tuberculous Pleural Effusion and Malignant Pleural Effusion: A Meta-Analysis.Respiration. 2018;95(6):469-477. doi: 10.1159/000486963. Epub 2018 Mar 14. Respiration. 2018. PMID: 29539604 Review.
Cited by
-
Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis.Ann Med. 2021 Dec;53(1):558-566. doi: 10.1080/07853890.2021.1906943. Ann Med. 2021. PMID: 33818231 Free PMC article.
-
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review.Transl Lung Cancer Res. 2021 Mar;10(3):1557-1570. doi: 10.21037/tlcr-20-1111. Transl Lung Cancer Res. 2021. PMID: 33889529 Free PMC article. Review.
-
Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma.Transl Lung Cancer Res. 2023 Sep 28;12(9):1887-1895. doi: 10.21037/tlcr-23-151. Epub 2023 Sep 1. Transl Lung Cancer Res. 2023. PMID: 37854163 Free PMC article.
-
Age affects the diagnostic accuracy of the cancer ratio for malignant pleural effusion.BMC Pulm Med. 2023 Jun 7;23(1):198. doi: 10.1186/s12890-023-02475-8. BMC Pulm Med. 2023. PMID: 37286973 Free PMC article.
-
Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.Clinics (Sao Paulo). 2021 Apr 26;76:e2515. doi: 10.6061/clinics/2021/e2515. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 33909825 Free PMC article.
References
-
- Porcel J. M., Light R. W. Diagnostic approach to pleural effusions in adults. American Family Physician. 2006;73:1211–1220. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials